These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3788434)

  • 1. [The pathophysiology of malignant lymphoma from the hematological point of view. 3. Changes in peripheral blood lymphocyte count and the recovery of cell-mediated immune function after therapy of T-, B-malignant lymphomas and Hodgkin's disease].
    Kinoshita K; Amagasaki T; Momita S; Ikeda S; Ichimaru M; Kamihira S
    Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1068-80. PubMed ID: 3788434
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma.
    Hancock BW; Bruce L; Ward AM; Richmond J
    Clin Oncol; 1977 Jun; 3(2):137-44. PubMed ID: 872467
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
    ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
    J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
    Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
    Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in human lymphocyte subpopulation in Hodgkin's lymphoma.
    Rejthar A; Patera J; Rejtharová A; Hrdlicková N
    Neoplasma; 1976; 23(4):371-5. PubMed ID: 1087377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 14. The lymphomas.
    DeVita VT; Canellos GP
    Semin Hematol; 1999 Oct; 36(4 Suppl 7):84-94. PubMed ID: 10595757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in the treatment of hematological malignancies. V. Recent results of chemotherapy and major prognostic factors in patients with T-cell lymphoma, B-cell lymphoma and Hodgkin's disease].
    Ohta K; Shimoyama M
    Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):802-8. PubMed ID: 2794662
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte subpopulations in Hodgkin's disease and non-Hodgkin's lymphoma and the effects of radiotherapy.
    Balasem AN; Barker CR
    Clin Radiol; 1984 Sep; 35(5):353-7. PubMed ID: 6236011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.